Biomarkers Accurately Inform Treatment Decisions in Localised Prostate Cancer

Eur Urol Focus. 2022 May;8(3):643-645. doi: 10.1016/j.euf.2022.03.011. Epub 2022 Mar 23.

Abstract

Despite diverse levels of evidence supporting the use of biomarkers at various time points in the management pathway for localised prostate cancer, high-level evidence from prospective head-to-head trials for recommending their routine use to inform treatment decisions is still lacking.

MeSH terms

  • Biomarkers
  • Humans
  • Male
  • Prospective Studies
  • Prostatectomy*
  • Prostatic Neoplasms* / surgery

Substances

  • Biomarkers